List view / Grid view
28 June 2018 | By Merck
Monoclonal antibodies (mAbs) are widely manufactured by many biopharmaceutical companies to treat a myriad of diseases ranging from Alzheimer’s disease, Parkinson’s disease, ulcerative colitis, and many types of cancers...
20 June 2018 | By European Pharmaceutical Review
Researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the FDA to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.
14 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Paediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones...
28 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Killing gut bacteria with drugs weakens immune response...
16 March 2018 | By European Pharmaceutical Review
Scientists in Germany have developed a test using electric fields and Raman spectroscopy to ascertain specific antibiotic resistance of pathogens and thus enable the prescription of effective treatment.
6 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
1 March 2018 | By Dr Payam Behzadi
In parallel with the use of a wide range of antibiotics for treating infectious diseases worldwide, antimicrobial resistance has significantly increased. For this reason, the application of an advanced pangenomic technique like DNA microarray can be an effective, rapid, accurate, sensitive, specific and flexible methodology for detecting, identifying and determining…
7 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Scientists and chemists are re-examining old compounds to see whether they could hold the key to a future drug to combat increasingly resistant bacteria...
22 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A team of computer scientists have developed an algorithm that can rapidly search massive databases to discover novel variants of known antibiotics...
14 December 2017 | By European Pharmaceutical Review
Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have announced a formal agreement to work together.
6 December 2017 | By European Pharmaceutical Review
A study by the University of Warwick and the Francis Crick Institute has enabled a deeper understanding of the mechanism of action of antibiotic drug, D-cycloserine, which holds promise for future TB treatment.
23 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Glatiramer acetate, a drug used to treat multiple sclerosis, has been found to have an effect on drug-resistant bacteria...
24 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found a way of reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days...
12 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Polyphor Ltd has announced €5m funding, in order to support and accelerate the development of an inhaled dosage form of murepavadin...
25 September 2017 | By Steve Bremer (European Pharmaceutical Review)
NPL's new approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise, will see it focus on some of the world’s biggest health challenges, from supporting the diagnosis and treatment of cancer and dementia, to reducing attrition rates in drug development, to creating new…
Send this to a friend
Follow: